Subtype
Digestive System Carcinoma
CI-CAN-00000812Explore in graph →
2,124 active trials27 approved drugs139 evidence items
- NCIt
- C96963
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000812Explore in graph →
Clinical trials
7,545 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (885)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00784290 | Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 35 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT01337492 | Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT) | terminated | Early Phase 1 | 2 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 21, 2012 | clinicaltrials |
| NCT00734890 | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 18 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00031941 | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00088868 | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma | completed | Phase 1 | 40 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT01095120 | Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer | unknown | Phase 2 | 27 | Genta IncorporatedINDUSTRY | 2 | Mar 15, 2012 | clinicaltrials |
| NCT00988195 | Study of Pegylated Human Recombinant Arginase for Liver Cancer | completed | Phase 1 | 15 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01092091 | Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)(BCT-100-002) | completed | Phase 1 / Phase 2 | 20 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01348009 | Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 63 | Genta IncorporatedINDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT01543412 | Second Line Chemotherapy for Advanced Pancreatic Cancer(SLAP) | completed | Phase 2 | 50 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Mar 5, 2012 | clinicaltrials |
| NCT00821912 | TaxXel: Taxotere and Xeloda in Esophageal Cancer(TaxXel) | unknown | Phase 1 / Phase 2 | 93 | Karolinska University HospitalOTHER | 2 | Feb 28, 2012 | clinicaltrials |
| NCT00151671 | Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer(IMPACT) | terminated | Phase 2 / Phase 3 | 35 | Rennes University HospitalOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT01318200 | Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC) | withdrawn | Phase 3 | 0 | Accuray IncorporatedINDUSTRY | 1 | Feb 20, 2012 | clinicaltrials |
| NCT01533324 | S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 32 | Second Military Medical UniversityOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
| NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | completed | Phase 2 | 24 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01525719 | Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma(CRAD001T) | unknown | Phase 2 | 40 | Ratchavithi HospitalOTHER_GOV | 0 | Feb 3, 2012 | clinicaltrials |
| NCT01088581 | Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma | completed | Phase 3 | 101 | Yonsei UniversityOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01131689 | Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 | 20 | Samsung Medical CenterOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01031784 | Radioactive Holmium Microspheres for the Treatment of Liver Metastases(HEPAR) | completed | Phase 1 | 15 | UMC UtrechtOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT01486992 | mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00721175 | Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma | completed | Phase 4 | 108 | Khon Kaen UniversityOTHER | 1 | Dec 23, 2011 | clinicaltrials |
| NCT01441388 | A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. | withdrawn | Phase 1 | 0 | PfizerINDUSTRY | 0 | Dec 20, 2011 | clinicaltrials |
| NCT01355107 | Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease | completed | — | 32 | University Hospital FreiburgOTHER | 1 | Dec 14, 2011 | clinicaltrials |
| NCT01489566 | Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients | unknown | Phase 3 | 300 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 14, 2011 | clinicaltrials |
| NCT00006379 | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA | completed | Phase 2 | 58 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00593008 | Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | terminated | Phase 1 | 5 | Massachusetts General HospitalOTHER | 1 | Dec 2, 2011 | clinicaltrials |
| NCT01245582 | Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients(SECOX) | withdrawn | Phase 3 | 0 | SanofiINDUSTRY | 0 | Nov 9, 2011 | clinicaltrials |
| NCT01459328 | Resource-Sparing Curative Treatment for Rectal Cancer | unknown | Phase 3 | 350 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 25, 2011 | clinicaltrials |
| NCT00519688 | UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma | completed | Phase 2 | 44 | National Taiwan University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00225290 | Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve | terminated | Phase 3 | 230 | TTY BiopharmINDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT01441453 | Transient Elastography in Hepatectomy for Hepatocellular Carcinoma | unknown | N/A | 120 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT01387061 | Resection for Multiple Hepatocellular Carcinomas (HCC) | completed | N/A | 87 | University of MilanOTHER | 1 | Sep 20, 2011 | clinicaltrials |
| NCT01429961 | Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 38 | Seoul National University HospitalOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00703365 | Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 45 | Mahidol UniversityOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00956475 | Quality of Life in Younger Leukemia and Lymphoma Survivors | completed | — | 48 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00732745 | Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction | terminated | Phase 1 | 9 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 22, 2011 | clinicaltrials |
| NCT00073736 | Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 28 | Ligand PharmaceuticalsINDUSTRY | 3 | Aug 12, 2011 | clinicaltrials |
| NCT01415063 | Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma | unknown | Phase 4 | 120 | Sun Yat-sen UniversityOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT01402180 | Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy(Nimotuzumab) | unknown | Phase 2 / Phase 3 | 128 | Fudan UniversityOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | unknown | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00922688 | Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients(AIRCo) | unknown | N/A | 30 | Medical Center AlkmaarOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT00725400 | Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma | withdrawn | Phase 2 | 450 | American Scitech InternationalOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT01398449 | Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0 | unknown | Phase 3 | 874 | Fudan UniversityOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00287222 | Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma | completed | Phase 2 | 21 | University of ArkansasOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT01126866 | Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy(APRIORI) | terminated | Phase 2 | 35 | National Center for Tumor Diseases, HeidelbergOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00882869 | XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 75 | Aegera TherapeuticsINDUSTRY | 1 | Jul 13, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Mar 26, 2012source: clinicaltrials